- Home
- FCEL vs HLVX Comparison
FCEL vs HLVX Comparison
Compare FCEL & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- HLVX
- Stock Information
- Founded
- FCEL 1969
- HLVX 2020
- Country
- FCEL United States
- HLVX United States
- Employees
- FCEL N/A
- HLVX N/A
- Industry
- FCEL Industrial Machinery/Components
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- FCEL Energy
- HLVX Health Care
- Exchange
- FCEL Nasdaq
- HLVX Nasdaq
- Market Cap
- FCEL 106.2M
- HLVX 104.3M
- IPO Year
- FCEL 1992
- HLVX 2022
- Fundamental
- Price
- FCEL $5.18
- HLVX $2.10
- Analyst Decision
- FCEL Hold
- HLVX Hold
- Analyst Count
- FCEL 5
- HLVX 1
- Target Price
- FCEL $9.43
- HLVX $2.00
- AVG Volume (30 Days)
- FCEL 1.8M
- HLVX 669.8K
- Earning Date
- FCEL 09-09-2025
- HLVX 11-06-2025
- Dividend Yield
- FCEL N/A
- HLVX N/A
- EPS Growth
- FCEL N/A
- HLVX N/A
- EPS
- FCEL N/A
- HLVX N/A
- Revenue
- FCEL $152,472,000.00
- HLVX N/A
- Revenue This Year
- FCEL $40.32
- HLVX N/A
- Revenue Next Year
- FCEL $36.17
- HLVX N/A
- P/E Ratio
- FCEL N/A
- HLVX N/A
- Revenue Growth
- FCEL 78.81
- HLVX N/A
- 52 Week Low
- FCEL $3.58
- HLVX $1.34
- 52 Week High
- FCEL $16.10
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- FCEL 66.21
- HLVX 55.20
- Support Level
- FCEL $3.93
- HLVX $2.07
- Resistance Level
- FCEL $4.53
- HLVX $2.11
- Average True Range (ATR)
- FCEL 0.28
- HLVX 0.03
- MACD
- FCEL 0.11
- HLVX 0.00
- Stochastic Oscillator
- FCEL 90.91
- HLVX 57.14
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.